Alexza Pharmaceuticals Inc. Management Discusses Q2 2013 Results (Webcast)

Aug. 8.13 | About: Alexza Pharmaceuticals, (ALXA)

Alexza Pharmaceuticals (ALXA): Q2 EPS of -$0.21 may not be comparable to consensus of $0.09.

Revenue of $40.8M may not be comparable to consensus of $14.17M. (PR)

The following audio is from an earnings conference call that will begin on August 8, 2013, at 5:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.